FULL SUPPLEMENT: Nordic European Cutaneous Oncodermatology Management (Necom 6): A Practical Algorithm Integrating Skincare for the Prevention and Treatment of Cutaneous Side Effects of Hormonal Cancer Therapy

May 2025 | Volume 24 | Issue 5 | Copyright © May 2025


Published online April 30, 2025

Ada Girnita MD PhD IFAAD FEADVa, Peter Bjerring MD DMSc FEADVb, Gabriela Llado Grove MD PhDc, Sampsa Kauppi MDd, Anneke Andriessen PhDe, Charles Lynde MD FRCPCf, Maxwell Sauder MD FRCPC DABDg, Andreas Stensvold MD PhDh

aSkin Cancer Center Karolinska University Hospital Stockholm, SwedenbDepartment of Dermatology, Aalborg University Hospital, DenmarkcDepartment of Dermatology, Copenhagen University Hospital, DenmarkdPrivate Practice, Terveystalo and Epilaser Oy, FinlandeRadboud UMC; Nijmegen and Andriessen Consultants, Malden, The NetherlandsfAmerican Board of Dermatology, Newton, Massachusetts; Royal College of Physicians and Surgeons of Canada, Ottawa ON, Canada; Department of Medicine University of Toronto, Toronto, ON, Canada; Lynderm Research, Markham, ON, CanadagAmerican Board of Dermatology, Newton, Massachusetts; Royal College of Physicians and Surgeons of Canada, Ottawa ON,Canada; Department of Medicine University of Toronto; Onco-dermatologist, Princess Margaret Cancer Centre, Toronto, ON, CanadahØstfold Hospital Trust, Grålum, Norway

Abstract
In this issue:

A Practical Algorithm for the Prevention and Treatment of Cutaneous Side Effects of Hormonal Cancer Therapy
Preventing and treating common dermatologic toxicities associated with hormonal cancer therapies is an essential component of care to improve patient quality of life, adherence to cancer treatment, and treatment outcomes.
Read More
Close Menu